Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tadashi Katoh is active.

Publication


Featured researches published by Tadashi Katoh.


Chemistry: A European Journal | 2009

Total Synthesis of the Bicyclic Depsipeptide HDAC Inhibitors Spiruchostatins A and B, 5 -epi-Spiruchostatin B, FK228 (FR901228) and Preliminary Evaluation of Their Biological Activity

Koichi Narita; Kazuhiro Watanabe; Toshiya Takizawa; Takamasa Oguchi; Kyosuke Kudo; Keisuke Matsuhara; Hideki Abe; Takao Yamori; Minoru Yoshida; Tadashi Katoh

The bicyclic depsipeptide histone deacetylase (HDAC) inhibitors spiruchostatins A and B, 5-epi-spiruchostatin B and FK228 were efficiently synthesized in a convergent and unified manner. The synthetic method involved the following crucial steps: i) a Julia-Kocienski olefination of a 1,3-propanediol-derived sulfone and a L- or D-malic acid-derived aldehyde to access the most synthetically challenging unit, (3S or 3R,4E)-3-hydroxy-7-mercaptohept-4-enoic acid, present in a D-alanine- or D-valine-containing segment; ii) a condensation of a D-valine-D-cysteine- or D-allo-isoleucine-D-cysteine-containing segment with a D-alanine- or D-valine-containing segment to directly assemble the corresponding seco-acids; and iii) a macrocyclization of a seco-acid using the Shiina method or the Mitsunobu method to construct the requisite 15- or 16-membered macrolactone. The present synthesis has established the C5 stereochemistry of spiruchostatin B. In addition, HDAC inhibitory assay and the cell-growth inhibition analysis of the synthesized depsipeptides determined the order of their potency and revealed some novel aspects of structure-activity relationships. It was also found that unnatural 5-epi-spiruchostatin B shows extremely high selectivity (ca. 1600-fold) for class I HDAC1 (IC(50)=2.4 nM) over class II HDAC6 (IC(50)=3900 nM) with potent cell-growth-inhibitory activity at nanomolar levels of IC(50) values.


Chemistry: A European Journal | 2009

Enantioselective Total Synthesis of (−)‐Candelalides A, B and C: Potential Kv1.3 Blocking Immunosuppressive Agents

Takamasa Oguchi; Kazuhiro Watanabe; Koichi Ohkubo; Hideki Abe; Tadashi Katoh

Novel Kv1.3 blocking immunosuppressants, (-)-candelalides A, B and C, were efficiently synthesized for the first time in a convergent and unified manner starting from (+)-5-methyl-Wieland-Miescher ketone. The synthetic method involved the following key steps: i) a strategic [2,3]-Wittig rearrangement of a stannylmethyl ether to install the stereogenic center at C9 and the exo-methylene function at C8 present in the decalin portion; ii) a straightforward coupling of a trans-decalin portion (BC ring) and a gamma-pyrone moiety through the C16-C3 bond to assemble the requisite carbon framework; and iii) a construction of a characteristic di or tetrahydropyran ring (A ring) by internal nucleophilic ring closure of a hydroxy aldehyde or a hydroxy epoxide. The present total synthesis has fully established the absolute configuration of these natural products.


Organic Letters | 2009

Ir-catalyzed oxidative desymmetrization of meso-diols.

Takeyuki Suzuki; Kazem Ghozati; Tadashi Katoh; Hiroaki Sasai

The catalytic oxidative desymmetrization of meso-diols was realized using a chiral iridium catalyst. In particular, the reaction is effective for the cyclic diols to give the corresponding hydroxy ketones in high chemical yields with high ees. With this reaction as a key step, a short-step synthesis of common intermediate of ottelione and scyphostatin was achieved.


Heterocycles | 2010

ENANTIOSELECTIVE TOTAL SYNTHESIS OF NOVEL DITERPENOID PYRONES (+)-SESQUICILLIN AND (-)-NALANTHALIDE FROM FUNGAL FERMENTATIONS

Tadashi Katoh; Takamasa Oguchi; Kazuhiro Watanabe; Hideki Abe

We efficiently synthesized (+)-sesquicillin (a glucocorticoid antagonist) and (-)-nalanthalide (a potassium channel Kvl.3 blocker) in a convergent and unified manner starting from (+)-5-methyl-Wieland-Miescher ketone. The synthesis involved the following key steps: (i) a [2,3]-Wittig rearrangement of a stannylmethyl ether to install the stereogenic center at C9 and the exo-methylene functionality at C8 present in the trans-decalin portion, (ii) a coupling reaction of a trans-decalin portion with a γ-pyrone moiety to assemble the requisite whole carbon framework, and (iii) a conversion of a γ-pyrone moiety to an α-pyrone ring to produce (+)-sesquicillin. The present total synthesis has verified the absolute configuration of these natural products.


Heterocycles | 2009

SPIROCYCLIZATION OF SIX-MEMBERED CYCLIC N-ACYLIMINIUM IONS WITH A CONJUGATED DIENE

Hideki Abe; Yoshinori Muramatsu; Kazuhiro Watanabe; Sakae Aoyagi; Chihiro Kibayashi; Tadashi Katoh

Intramolecular spirocyclization of six-membered cyclic N-acyliminium ions with a tethered conjugated diene has been studied. The reaction of an N-acyliminium ion bearing an endocyclic amide carbonyl group led to spirocyclization to give a l-azaspiro[5.5]undecane compound.


Angewandte Chemie | 2004

Total Synthesis of (+)-Scyphostatin, a Potent and Specific Inhibitor of Neutral Sphingomyelinase†

Munenori Inoue; Wakako Yokota; Modachur G. Murugesh; Takashi Izuhara; Tadashi Katoh


Chemistry: A European Journal | 2008

Highly Efficient Total Synthesis of the Marine Natural Products (+)‐Avarone, (+)‐Avarol, (−)‐Neoavarone, (−)‐Neoavarol and (+)‐Aureol

Junji Sakurai; Takamasa Oguchi; Kazuhiro Watanabe; Hideki Abe; Syu-ichi Kanno; Masaaki Ishikawa; Tadashi Katoh


European Journal of Organic Chemistry | 2011

Enantioselective Total Synthesis of (+)-Stachyflin: A Potential Anti-Influenza A Virus Agent Isolated from a Microorganism

Junji Sakurai; Ohgi Takahashi; Kazuhiro Watanabe; Tadashi Katoh


Tetrahedron Letters | 2006

Convergent and enantioselective total synthesis of (−)-nalanthalide, a potential Kv1.3 blocking immunosuppressant

Toshiaki Abe; Katsuhiko Iwasaki; Munenori Inoue; Takeyuki Suzuki; Kazuhiro Watanabe; Tadashi Katoh


Chemical Communications | 2010

Total synthesis of (+)-stachyflin: a potential anti-influenza A virus agent

Kazuhiro Watanabe; Junji Sakurai; Hideki Abe; Tadashi Katoh

Collaboration


Dive into the Tadashi Katoh's collaboration.

Top Co-Authors

Avatar

Kazuhiro Watanabe

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hideki Abe

Tokyo University of Pharmacy and Life Sciences

View shared research outputs
Top Co-Authors

Avatar

Takamasa Oguchi

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Munenori Inoue

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Koichi Narita

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshiya Takizawa

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Junji Sakurai

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Takao Yamori

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge